Comparison of Analgesic Consumption by WHO Analgesic Level Between 2023 and 2022. by Myriam Aïche (22290591)

Subjects:

Demographic and Clinical Characteristics of Children Exposed or Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®). by Myriam Aïche (22290591)

Subjects:

Multivariate Linear Regression Analysis of Factors Associated with Pain Scores (VAS) in Children Aged 7–12. by Myriam Aïche (22290591)

Subjects:

Flow chart. by Myriam Aïche (22290591)

Subjects:

Linear regression. by Myriam Aïche (22290591)

Subjects:

Comparison of Pain Scores (VAS) Between Children Exposed and Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®). by Myriam Aïche (22290591)

Subjects:

Achieving Improved Ion Swarm Shaping Based on Ion Leakage Control in Ion Mobility Spectrometry by Jiyao Wang (2121157)

Subjects:

Synthesis and Biological Evaluation of MEK/mTOR Multifunctional Inhibitors as Novel Anticancer Agents by Marcian E. Van Dort (21374093)

Subjects:

Functional enzyme at steady state over flow rate. by Fabian Santiago (8384421)

Subjects:

Estimated rate and dissociation constants. by Fabian Santiago (8384421)

Subjects:

Functional enzyme over time by inhibition pathway. by Fabian Santiago (8384421)

Subjects:

Inhibition of factor X activation is weak in the absence of TFPI. by Fabian Santiago (8384421)

Subjects:

Experimental measurements and uncertainty in model predictions of factor X activation. by Fabian Santiago (8384421)

Subjects:

Alternative model without reaction 7: Estimated rate and dissociation constants. by Fabian Santiago (8384421)

Subjects:

Proposed mechanisms of TFPI inhibition of factor X activation. by Fabian Santiago (8384421)

Subjects:

Inhibition of factor X activation under flow. by Fabian Santiago (8384421)

Subjects:

The global numbers of prevalent cases (A), incident cases (B), deaths (C), DALYs (D), and corresponding rates of chronic obstructive pulmonary disease per 100,000 population in old... by Kaifang Meng (13848535)

Subjects:

Prevalence and EAPC of chronic obstructive pulmonary disease among adults aged ≥70 years at the global and regional levels, from 1990 to 2021. by Kaifang Meng (13848535)

Subjects:

Trends of death rates due to chronic obstructive pulmonary disease attributable to each risk factor among adults aged ≥70 years in 5 sociodemographic index regions, from 1990–2021.... by Kaifang Meng (13848535)

Subjects:

Map showing prevalence (A), incidence (B), deaths (C), and DALYs (D) rates of chronic obstructive pulmonary disease per 100,000 population among adults aged ≥70 years in 2021, by c... by Kaifang Meng (13848535)

Subjects: